SAR study on arylmethyloxyphenyl scaffold: Looking for a P-gp nanomolar affinity

European Journal of Medicinal Chemistry
2014.0

Abstract

Starting from the previously developed P-gp ligands 1a and 1b (EC₅₀ = 0.25 μM and 0.65 μM, respectively), new arylmethyloxyphenyl derivatives have been synthesized as P-gp modulators in order to investigate: (i) the effect of small electron-donor groups (OMe) (5-11), (ii) the effect of the replacement of methoxy groups with an electron-withdrawal substituent (Cl) on C-ring (13) (iii) the effect induced by the replacement of C-ring with heteroaromatic cycles such as thiophene and pyrimidine (13, 15, 16), (iv) the effect induced by molecular constriction on C ring (14, 17, 18) on P-gp modulating activity. The results demonstrated that P-gp inhibition potency is strongly correlated to the number of methoxy groups in the A-ring whereas the methoxylation of C-ring seems to poorly affect P-gp activity. The best result was found for compound 10 that displays a nanomolar affinity (EC₅₀ = 7.1 nM) towards P-gp pump and, in the meantime lacks of activity against MRP1 pump.

Knowledge Graph

Similar Paper

SAR study on arylmethyloxyphenyl scaffold: Looking for a P-gp nanomolar affinity
European Journal of Medicinal Chemistry 2014.0
Synthesis and Biological Evaluation of (Hetero)Arylmethyloxy- and Arylmethylamine-phenyl Derivatives as Potent P-glycoprotein Modulating Agents
Journal of Medicinal Chemistry 2008.0
Arylmethyloxyphenyl Derivatives:  Small Molecules Displaying P-Glycoprotein Inhibition
Journal of Medicinal Chemistry 2006.0
4-Biphenyl and 2-naphthyl substituted 6,7-dimethoxytetrahydroisoquinoline derivatives as potent P-gp modulators
Bioorganic & Medicinal Chemistry 2008.0
Small P-gp modulating molecules: SAR studies on tetrahydroisoquinoline derivatives
Bioorganic & Medicinal Chemistry 2008.0
1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1
European Journal of Medicinal Chemistry 2019.0
Design and synthesis of aminoester heterodimers containing flavone or chromone moieties as modulators of P-glycoprotein-based multidrug resistance (MDR)
Bioorganic & Medicinal Chemistry 2018.0
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: Further restriction of molecular flexibility maintains high potency and efficacy
Bioorganic & Medicinal Chemistry Letters 2011.0
Design and synthesis of new potent N,N -bis(arylalkyl)piperazine derivatives as multidrug resistance (MDR) reversing agents
European Journal of Medicinal Chemistry 2018.0
Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers
European Journal of Medicinal Chemistry 2021.0